arginine vasopressin has been researched along with substance p, prolyl(2)-tryptophan(7,9)- in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chowdrey, HS; Jessop, D; Larsen, PJ; Lightman, SL; Patel, H | 1 |
| Matsuda, T; Mori, M; Tsushima, H | 1 |
2 other study(ies) available for arginine vasopressin and substance p, prolyl(2)-tryptophan(7,9)-
| Article | Year |
|---|---|
Substance P inhibits the release of anterior pituitary adrenocorticotrophin via a central mechanism involving corticotrophin-releasing factor-containing neurons in the hypothalamic paraventricular nucleus.
Topics: Adrenocorticotropic Hormone; Animals; Arginine Vasopressin; Corticosterone; Corticotropin-Releasing Hormone; Histocytochemistry; In Situ Hybridization; Injections, Intraventricular; Male; Neurons; Paraventricular Hypothalamic Nucleus; Pituitary Gland, Anterior; Rats; Rats, Sprague-Dawley; RNA, Messenger; Substance P | 1993 |
Substance P injected into the hypothalamic supraoptic nucleus causes antidiuresis through the release of arginine-vasopressin in water-loaded and ethanol-anesthetized rats.
Topics: Anesthesia; Animals; Arginine Vasopressin; Blood Pressure; Diuresis; Ethanol; Heart Rate; Injections; Male; Osmolar Concentration; Paraventricular Hypothalamic Nucleus; Radioimmunoassay; Rats; Rats, Wistar; Respiration; Substance P; Supraoptic Nucleus; Water | 1993 |